Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
31.5K
-
Shares change
-
-68.8K
-
Total reported value, excl. options
-
$2.49M
-
Value change
-
-$5.43M
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$78.93
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q4 2023
3 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q4 2023.
TransMedics Group, Inc. - Common Stock (TMDX) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.5K shares
of 33.9M outstanding shares and own 0.09% of the company stock.
Largest 10 shareholders include FMR LLC (4.83M shares), BlackRock Inc. (2.55M shares), VANGUARD GROUP INC (1.87M shares), MACQUARIE GROUP LTD (1.53M shares), FRED ALGER MANAGEMENT, LLC (1.34M shares), Invesco Ltd. (1.14M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.09M shares), LORD, ABBETT & CO. LLC (1.03M shares), ArrowMark Colorado Holdings LLC (1.02M shares), and EVENTIDE ASSET MANAGEMENT, LLC (994K shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.